Financials
- Market Capitalization 2.69 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1758 | ALMS Alumis Inc. - Common Stock | 21.81 USD | -2.55% | -7.27% | -21.24% | +383.59% | 2.82 B USD | ||
| 1785 | ATAI AtaiBeckley Inc. - Common Stock | 7.34 USD | +0.69% | -0.54% | +2.23% | +85.82% | 2.72 B USD | ||
| 1796 | NRIX Nurix Therapeutics, Inc. - Common stock | 25.78 USD | -1.64% | -3.52% | +12.28% | +129.97% | 2.68 B USD | ||
| 1814 | VRDN Viridian Therapeutics, Inc. - Common Stock | 23.16 USD | +0.35% | -3.82% | +23.19% | +3.16% | 2.62 B USD |
Frequently asked questions about SELLAS Life Sciences Group, Inc. Common Stock
What is the SELLAS Life Sciences Group, Inc. Common Stock stock price today?
The current price of SELLAS Life Sciences Group, Inc. Common Stock (SLS) is 13.34. Over the past 24 hours, the stock has changed by +0.98%. Follow the SLS chart for real-time price dynamics.
What is the stock ticker of SELLAS Life Sciences Group, Inc. Common Stock?
SELLAS Life Sciences Group, Inc. Common Stock trades under the ticker SLS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SELLAS Life Sciences Group, Inc. Common Stock stock going up?
SLS has changed by -8.38% over the last week, +33.40% over the last month, and +594.79% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of SELLAS Life Sciences Group, Inc. Common Stock?
SELLAS Life Sciences Group, Inc. Common Stock currently has a market capitalization of 2.69 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does SELLAS Life Sciences Group, Inc. Common Stock release financial reports?
Yes. You can track SELLAS Life Sciences Group, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were SELLAS Life Sciences Group, Inc. Common Stock earnings last quarter?
Last quarter, SELLAS Life Sciences Group, Inc. Common Stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was SELLAS Life Sciences Group, Inc. Common Stock net income for the last quarter?
SELLAS Life Sciences Group, Inc. Common Stock reported net income of -9.61 M for the last quarter. The previous quarter showed -8.41 M, which means net income changed by -14.25%.
How many employees does SELLAS Life Sciences Group, Inc. Common Stock have?
As of the latest available data, SELLAS Life Sciences Group, Inc. Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy SELLAS Life Sciences Group, Inc. Common Stock stock?
You can buy SELLAS Life Sciences Group, Inc. Common Stock (SLS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SELLAS Life Sciences Group, Inc. Common Stock stock?
Investing in SELLAS Life Sciences Group, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLS chart and related analysis on metatrader.com as part of your research.